0001209191-20-062404.txt : 20201208
0001209191-20-062404.hdr.sgml : 20201208
20201208205643
ACCESSION NUMBER: 0001209191-20-062404
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201208
FILED AS OF DATE: 20201208
DATE AS OF CHANGE: 20201208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAPPS VICKIE L
CENTRAL INDEX KEY: 0001248190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 201376720
MAIL ADDRESS:
STREET 1: 2985 SCOTT STREET
CITY: VISTA
STATE: CA
ZIP: 92083
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Silverback Therapeutics, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-456-2900
MAIL ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-08
0
0001671858
Silverback Therapeutics, Inc.
SBTX
0001248190
CAPPS VICKIE L
500 FAIRVIEW AVENUE N, SUITE 600
SEATTLE
WA
98109
1
0
0
0
Common Stock
2020-12-08
4
P
0
9523
21.00
A
61576
D
The shares were purchased in the Issuer's initial public offering.
/s/ Jeffrey C. Pepe, Attorney-in-Fact
2020-12-08